These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 8318003)

  • 1. Separation and partial characterization of proteinases with substrate specificity for basic amino acids from human MOLT-4 T lymphocytes: identification of those inhibited by variable-loop-V3 peptides of HIV-1 (human immunodeficiency virus-1) envelope glycoprotein.
    Harvima IT; Harvima RJ; Nilsson G; Ivanoff L; Schwartz LB
    Biochem J; 1993 Jun; 292 ( Pt 3)(Pt 3):711-8. PubMed ID: 8318003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular proteases involved in the pathogenicity of enveloped animal viruses, human immunodeficiency virus, influenza virus A and Sendai virus.
    Kido H; Niwa Y; Beppu Y; Towatari T
    Adv Enzyme Regul; 1996; 36():325-47. PubMed ID: 8869754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between a membrane-associated serine proteinase of U-937 monocytes and peptides from the V3 loop of the human immunodeficiency virus type 1 (HIV-1) gp120 envelope glycoprotein.
    Avril LE; Di Martino-Ferrer M; Barin F; Gauthier F
    FEBS Lett; 1993 Feb; 317(1-2):167-72. PubMed ID: 8428626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of V3 loop-binding protein(s) of Molt-4 and U937 cells.
    Xu Y; Murakami T; Kawase S; Uchiyama T; Hattori T
    AIDS Res Hum Retroviruses; 1995 May; 11(5):563-70. PubMed ID: 7576912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell membrane-associated serine protease, tryptase TL2, binds human immunodeficiency virus type 1 gp120 and cleaves the third-variable-domain loop of gp120. Neutralizing antibodies of human immunodeficiency virus type 1 inhibit cleavage of gp120.
    Niwa Y; Yano M; Futaki S; Okumura Y; Kido H
    Eur J Biochem; 1996 Apr; 237(1):64-70. PubMed ID: 8620895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic multimeric peptides derived from the principal neutralization domain (V3 loop) of human immunodeficiency virus type 1 (HIV-1) gp120 bind to galactosylceramide and block HIV-1 infection in a human CD4-negative mucosal epithelial cell line.
    Yahi N; Sabatier JM; Baghdiguian S; Gonzalez-Scarano F; Fantini J
    J Virol; 1995 Jan; 69(1):320-5. PubMed ID: 7983725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: a possible function in viral fusion?
    Clements GJ; Price-Jones MJ; Stephens PE; Sutton C; Schulz TF; Clapham PR; McKeating JA; McClure MO; Thomson S; Marsh M
    AIDS Res Hum Retroviruses; 1991 Jan; 7(1):3-16. PubMed ID: 2015114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tryptase TL2 in the membrane of human T4+ lymphocytes is a novel binding protein of the V3 domain of HIV-1 envelope glycoprotein gp 120.
    Kido H; Fukutomi A; Katunuma N
    FEBS Lett; 1991 Jul; 286(1-2):233-6. PubMed ID: 1677898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein.
    Peet NM; McKeating JA; de Souza JB; Roitt IM; Delves PJ; Lund T
    Virology; 1998 Nov; 251(1):59-70. PubMed ID: 9813203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applications of biotinylated V3 loop peptides of human immunodeficiency virus type 1 to flow cytometric analyses and affinity chromatographic techniques.
    Murakami T; Matsushita S; Maeda Y; Takatsuki K; Uchiyama T; Hattori T
    Biochim Biophys Acta; 1993 Apr; 1181(2):155-62. PubMed ID: 8481404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guinea pig lung tryptase. Localisation to mast cells and characterisation of the partially purified enzyme.
    McEuen AR; He S; Brander ML; Walls AF
    Biochem Pharmacol; 1996 Jul; 52(2):331-40. PubMed ID: 8694858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural requirements for and consequences of an antiviral porphyrin binding to the V3 loop of the human immunodeficiency virus (HIV-1) envelope glycoprotein gp120.
    Neurath AR; Strick N; Debnath AK
    J Mol Recognit; 1995; 8(6):345-57. PubMed ID: 9052975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A principal neutralizing domain of human immunodeficiency virus type 1 interacts with proteinase-like molecule(s) at the surface of Molt-4 clone 8 cells.
    Murakami T; Hattori T; Takatsuki K
    Biochim Biophys Acta; 1991 Sep; 1079(3):279-84. PubMed ID: 1911851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicatalytic high-molecular-weight neutral endopeptidase from human kidney.
    Zolfaghari R; Baker CR; Amirgholami A; Canizaro PC; Behal FJ
    Arch Biochem Biophys; 1987 Oct; 258(1):42-50. PubMed ID: 3310903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of U-937 membrane-associated cathepsin G by GP120 (IIIB) and V3 loop-derived peptides from several strains of HIV-1.
    Avril LE; di Martino-Ferrer M; Brillard-Bourdet M; Gauthier F
    FEBS Lett; 1995 Jul; 367(3):251-6. PubMed ID: 7607317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel membrane-bound serine esterase in human T4(+)-lymphocytes is a binding protein of envelope glycoprotein gp120 of HIV-1.
    Kido H; Fukutomi A; Katunuma N
    Biomed Biochim Acta; 1991; 50(4-6):781-9. PubMed ID: 1686971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The V3 loop of human immunodeficiency virus type-1 envelope protein is a high-affinity ligand for immunophilins present in human blood.
    Endrich MM; Gehring H
    Eur J Biochem; 1998 Mar; 252(3):441-6. PubMed ID: 9546659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multibranched peptide constructs derived from the V3 loop of envelope glycoprotein gp120 inhibit human immunodeficiency virus type 1 infection through interaction with CD4.
    Benjouad A; Chapuis F; Fenouillet E; Gluckman JC
    Virology; 1995 Jan; 206(1):457-64. PubMed ID: 7831801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic soluble analogs of galactosylceramide (GalCer) bind to the V3 domain of HIV-1 gp120 and inhibit HIV-1-induced fusion and entry.
    Fantini J; Hammache D; Delézay O; Yahi N; André-Barrès C; Rico-Lattes I; Lattes A
    J Biol Chem; 1997 Mar; 272(11):7245-52. PubMed ID: 9054420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the HIV type 1 glycoprotein 120 V3 loop in determining coreceptor usage.
    Verrier F; Borman AM; Brand D; Girard M
    AIDS Res Hum Retroviruses; 1999 May; 15(8):731-43. PubMed ID: 10357469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.